H-1B filings

Does Viridian Therapeutics, Inc. sponsor H-1B?

Yes, according to public filings. Viridian Therapeutics, Inc. filed 4 H-1B labor condition applications in fiscal years 2025-2026, including 1 in fiscal year 2026.

USCIS approved 5 H-1B petitions for this employer in fiscal years 2025-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026111
2025333

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20261020
20250020

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Director, Safety Science, Pharmacovigilance1$255,000 - $255,000$255,000
Clinical Trial Manager1$156,382 - $156,382$156,382
Director, R&D Quality Pv1$220,000 - $220,000$220,000
Senior Manager, Qc Tech Services Systems1$145,000 - $145,000$145,000

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

LocationApplications
Waltham, MA4

Sources

Data release 2026q4, built on October 29, 2026.